New Technique Can Find Noncoding Cancer Drivers
An American-British team has developed a method for assessing how important mutations in specific noncoding regions of the genome are likely to be, and used it to look at nearly 100 cancer genomes to identify likely driver mutations in noncoding locations. They published their results in the Oct. 4, 2013, issue of Science. Interpreting the meaning of a mutation in a protein-coding sequence is hard enough. Even within the poster children of genetic risk, BRCA1 and BRCA2 genes, somewhere around 10 percent of mutations are “variants of unknown significance” that may or may not raise cancer risk.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter